4th Quarter - Report

BGR GOVERNMENT AFFAIRS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HCR implementation; PDUFA reauthorization; Part D; patent reform

LobbyistCovered position, as disclosed
DAVID BOYER See prior filing
RYAN LONG See prior filing
JENNIFER LARKIN LUKAWSKI See prior filing
ROBERT WOOD See prior filing

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.